Biopesticides have emerged as a global trend to minimize the risks associated with synthetic agrochemicals. However, their stability and efficacies remain challenges for widespread application. Herein, co-assembled nanoparticles (AT NPs or AP NPs) based on azadirachtin (AZA) and tannic acid (TA) or phenylalanine (PA) are constructed in aqueous solution through self-assembly technology. The small particle size, low PDI, high ζ-potential, and related other physicochemical characteristics of nanoparticles can improve wettability, adhesiveness, rain erosion resistance, and photostability compared to the commercial AZA formulation. Importantly, co-assemblies with bidirectional pH-responsive disassembly in acidic or alkaline solutions, allow them to respond to microenvironmental stimuli of targets and enable controlled release of AZA. The nanosystems demonstrated remarkable in vitro and in vivo insecticidal activities against Ostrinia furnacalis and Aphis gossypii. This study illustrates a distinctive perspective for developing eco-friendly nanosystems, highlighting a water-based treatment method for biopesticides with improved physicochemical properties and utilization efficiency.

The insulin receptor (IR) is a transmembrane protein that is activated by ligands in insulin signaling pathways. The IR has been considered as a novel therapeutic target for clinical intervention, considering the overexpression of its protein and A-isoform in multiple cancers, Alzheimer’s disease, and Type 2 diabetes mellitus in humans. Meanwhile, it may also serve as a potential target in pest management due to its multiple physiological influences in insects. In this review, we provide an overview of the structural and molecular biology of the IR, functions of IRs in humans and insects, physiological and nonpeptide small molecule modulators of the IR, and the regulating mechanisms of the IR. Xenobiotic compounds and the corresponding insecticidal chemicals functioning on the IR are also discussed. This review is expected to provide useful information for a better understanding of human IR-related diseases, as well as to facilitate the development of novel small-molecule activators and inhibitors of the IR for use as medicines or pesticides.